Stock Price Quote

CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE271.75-2.45 (-0.89 %)
PREV CLOSE ( ) 274.20
OPEN PRICE ( ) 275.75
BID PRICE (QTY) 271.55 (136)
OFFER PRICE (QTY) 271.95 (321)
VOLUME 16879
TODAY'S LOW / HIGH ( )270.55 277.90
52 WK LOW / HIGH ( )206.45 352.3
NSE272.50-2.4 (-0.87 %)
PREV CLOSE( ) 274.90
OPEN PRICE ( ) 276.00
BID PRICE (QTY) 272.45 (307)
OFFER PRICE (QTY) 272.65 (153)
VOLUME 348549
TODAY'S LOW / HIGH( ) 270.65 277.95
52 WK LOW / HIGH ( )206.5 352.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX

NEWS

17Feb Zydus Cadila launches fast tracked pro
Zydus Cadila has launched a fast tracked programme to develop vaccine fo..
14Feb Cadila Healthcare trades in green on t
Cadila Healthcare is currently trading at Rs. 270.50, up by 1.75 points..
13Feb Zydus Cadila gets USFDA’s nod for Mesa
Zydus Cadila has received the final approval from the USFDA to market Me..
11Feb Infosys, PNC Infratech and Info Edge t
Infosys has signed a definitive agreement to acquire Simplus, one of the..
11Feb Zydus Cadila gets USFDA’s nod for Fluo
Zydus Cadila has received the final approval from the USFDA to market Fl..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit281616021
Gross Profit 3218 19285
Operating Profit 454623667
Net Sales 1848664927

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  16102.15 (0.99%)
M.Cap ( in Cr)34147.63
Procter&Gamble Healt (BSE)
peergroup  4168.05 (1.91%)
M.Cap ( in Cr)6910.57
Sanofi India (BSE)
peergroup  7127.25 (0.63%)
M.Cap ( in Cr)16570.76
Torrent Pharma (BSE)
peergroup  2216.45 (2.02%)
M.Cap ( in Cr)37524.57
Alkem Laboratories (BSE)
peergroup  2628.50 (1.08%)
M.Cap ( in Cr)31384.62

Shareholding Pattern

PROMOTERS 74.88%
NON-INSTITUTION 7.8%
MUTUAL FUNDS/UTI 7.11%
FI/BANKS/INSURANCE 5.46%
GOVERNMENT 0.13%
FII 0%

About Cadila Healthcare Ltd.

Cadila Healthcare Ltd. was incorporated in the year 1995. Its today's share price is 274.2. Its current market capitalisation stands at Rs 27799.73 Cr. In the latest quarter, company has reported Gross Sales of Rs. 131656 Cr and Total Income of Rs.133718 Cr. The company's management includes Ganesh N Nayak, Sharvil P Patel, Bhadresh K Shah, Apurva S Diwanji, Dharmishta N Raval, Mukesh M Patel, Nitin R Desai, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of CADILAHC and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X